Literature DB >> 3890434

Chemical synthesis of a pentaribonucleoside tetraphosphate constituting the 3'-acceptor stem sequence of E. coli tRNAIle using 2'-O-(3-methoxy-1,5-dicarbomethoxypentan-3-yl)-ribonucleoside building blocks. Application of a new achiral and acid-labile 2'-hydroxyl protecting group in tRNA synthesis.

A Sandström, M Kwiatkowski, J Chattopadhyaya.   

Abstract

A synthesis of a pentaribonucleotide fragment constituting the residues 59-63 of 3'-terminus of E. coli tRNAIle, 5'-ApGpUpCpC-3', has been carried out using a new, easily accessible and achiral 2'-ketal protecting group. The new 2'-ketal group has an additional advantage in that it is easily functionalized to the diamide with aqueous ammonia in the penultimate step of deblocking of fully protected oligoribonucleotides. Such a functionalization of the 2'-ketal group at the penultimate step of deblocking of the fully protected tRNA molecule enhances its relative rate of removal under an acidic condition with a minimum of damage of the target tRNA molecule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3890434     DOI: 10.3891/acta.chem.scand.39b-0273

Source DB:  PubMed          Journal:  Acta Chem Scand B        ISSN: 0302-4369


  3 in total

1.  Synthesis and applications of oligoribonucleotides with selected 2'-O-methylation using the 2'-O-[1-(2-fluorophenyl)-4-methoxypiperidin-4-yl] protecting group.

Authors:  B Beijer; I Sulston; B S Sproat; P Rider; A I Lamond; P Neuner
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

2.  A new 2'-hydroxyl protecting group for the automated synthesis of oligoribonucleotides.

Authors:  H Rastogi; D A Usher
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

3.  An efficient synthesis of RNA containing GS-441524: the nucleoside precursor of remdesivir.

Authors:  Ramkumar Moorthy; Samantha A Kennelly; Deborah J Rodriguez; Daniel A Harki
Journal:  RSC Adv       Date:  2021-09-22       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.